LAURA EVANS: Open Payments
NPI 1386065241 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 52 payments from 19 companies in 2025. Trend: 2023 $815 · 2024 $1,159 · 2025 $1,933
Food & beverage: $1,770Education: $163
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $535 |
| GENZYME CORPORATION | 8 | $376 |
| Gilead Sciences, Inc. | 5 | $236 |
| Daiichi Sankyo Inc. | 7 | $234 |
| SANOFI-AVENTIS U.S. LLC | 1 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Incyte Corporation | 2 | $46 |
| BeiGene USA, Inc. | 2 | $44 |
| Genentech USA, Inc. | 2 | $42 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $42 |
Products named: SARCLISA, ENHERTU, TAGRISSO, DATROWAY, Biktarvy, Trodelvy, LIBTAYO, BRUKINSA.
Industry payments across GA — which companies pay providers there.
